14-day Premium Trial Subscription Try For FreeTry Free
$0.590
+0.0074 (+1.27%)
At Close: May 03, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.531 $1.35 Friday, 3rd May 2024 VBIV stock ended at $0.590. This is 1.27% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.02% from a day low at $0.570 to a day high of $0.610.
90 days $0.530 $1.35
52 weeks $0.450 $3.47

Historical VBI Vaccines Inc. prices

Date Open High Low Close Volume
Jan 17, 2024 $0.603 $0.630 $0.599 $0.616 49 104
Jan 16, 2024 $0.620 $0.630 $0.578 $0.599 58 739
Jan 12, 2024 $0.620 $0.640 $0.580 $0.610 64 838
Jan 11, 2024 $0.630 $0.640 $0.610 $0.620 37 617
Jan 10, 2024 $0.617 $0.640 $0.617 $0.630 28 725
Jan 09, 2024 $0.623 $0.635 $0.610 $0.626 29 673
Jan 08, 2024 $0.616 $0.630 $0.600 $0.623 60 594
Jan 05, 2024 $0.637 $0.637 $0.608 $0.622 29 847
Jan 04, 2024 $0.620 $0.630 $0.590 $0.620 34 210
Jan 03, 2024 $0.620 $0.630 $0.582 $0.620 57 633
Jan 02, 2024 $0.590 $0.630 $0.588 $0.616 107 852
Dec 29, 2023 $0.600 $0.613 $0.570 $0.588 140 106
Dec 28, 2023 $0.570 $0.600 $0.565 $0.594 197 283
Dec 27, 2023 $0.600 $0.620 $0.550 $0.572 180 639
Dec 26, 2023 $0.570 $0.610 $0.570 $0.600 119 356
Dec 22, 2023 $0.565 $0.565 $0.538 $0.550 67 484
Dec 21, 2023 $0.568 $0.571 $0.522 $0.540 133 605
Dec 20, 2023 $0.585 $0.590 $0.557 $0.557 93 787
Dec 19, 2023 $0.574 $0.610 $0.574 $0.590 92 177
Dec 18, 2023 $0.620 $0.627 $0.576 $0.581 178 747
Dec 15, 2023 $0.660 $0.670 $0.620 $0.623 99 091
Dec 14, 2023 $0.670 $0.676 $0.600 $0.623 111 831
Dec 13, 2023 $0.710 $0.710 $0.647 $0.653 52 709
Dec 12, 2023 $0.690 $0.696 $0.670 $0.670 26 096
Dec 11, 2023 $0.715 $0.725 $0.671 $0.685 52 830
Click to get the best stock tips daily for free!

About VBI Vaccines Inc.

VBI Vaccines. VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP ... VBIV Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT